Avinza

Avinza is a brand name of morphine, approved by the FDA in the following formulation(s):

AVINZA (morphine sulfate - capsule, extended release; oral)

• 
  Manufacturer: KING PHARMS
  
  Approval date: March 20, 2002
  
  Strength(s): 120MG ^[RLD], 90MG
  


• 
  Manufacturer: KING PHARMS
  
  Approval date: December 18, 2008
  
  Strength(s): 45MG, 75MG
  

Has a generic version of Avinza been approved?

No. There is currently no therapeutically equivalent version of Avinza available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Avinza. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Oral morphine multiparticulate formulation
  Patent 6,066,339
  Issued: May 23, 2000
  Inventor(s): Stark; Paul & Cunningham; Sean & Moodley; Jagathesan
  Assignee(s): Elan Corporation, plc
  An oral morphine multiparticulate formulation for once-daily administration to a patient, comprising sustained release particles each having a core containing water soluble morphine and an osmotic agent, the core being coated with a rate-controlling polymer coat comprised of ammonio methacrylate copolymers in an amount sufficient to achieve therapeutically effective plasma levels of morphine over at least 24 hours in the patient.
  
  Patent expiration dates:
  
  
  • November 25, 2017
    
  
  
  
  • November 25, 2017
    
    ✓ 
    Drug product
  
  

See also...

• Avinza Consumer Information (Drugs.com)
• Avinza Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Avinza Consumer Information (Cerner Multum)
• Avinza Advanced Consumer Information (Micromedex)
• Morphine Consumer Information (Drugs.com)
• Morphine Concentrate Consumer Information (Wolters Kluwer)
• Morphine Extended-Release Capsules Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Consumer Information (Wolters Kluwer)
• Morphine Immediate-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine Soluble Tablets Consumer Information (Wolters Kluwer)
• Morphine Solution Consumer Information (Wolters Kluwer)
• Morphine Suppositories Consumer Information (Wolters Kluwer)
• Morphine Sustained-Release Tablets Consumer Information (Wolters Kluwer)
• Morphine IR Consumer Information (Cerner Multum)
• Morphine Consumer Information (Cerner Multum)
• DepoDur Advanced Consumer Information (Micromedex)
• Morphine Advanced Consumer Information (Micromedex)
• Morphine Epidural Advanced Consumer Information (Micromedex)
• Morphine Injection Advanced Consumer Information (Micromedex)
• Morphine Sulfate AHFS DI Monographs (ASHP)